Home » Topics » BioWorld Science

BioWorld Science
RSS

Second of two phase III trials for Viramidine under way

June 16, 2004

ARRY-142886 enters phase I trial for advanced cancer

June 16, 2004

A6 enters phase II trial to prevent clinical relapse in ovarian cancer patients

June 16, 2004

EDEMA1 study of DX-88 meets primary endpoint

June 16, 2004

FDA agrees to two pivotal protocols for pexelizumab

June 16, 2004

Teva and Active Biotech sign laquinimod licensing deal

June 16, 2004

Aptosyn phase III study in NSCLC fails to meet endpoints

June 16, 2004

Peripheral efficacious kappa opioid agonist with unprecedented selectivity

June 16, 2004

Phase I data on XR-5944 in patients with refractory advanced cancer

June 16, 2004

Preliminary data suggest epratuzumab plus rituximab is safe and effective in NHL

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...